Stop NAD+ Decline and Slow Down Your Aging – Dr. Nichola Conlon with Dave Asprey : 826

<p>In this episode of Bulletproof Radio, molecular biologist Dr. Nichola Conlon joins me to talk about the role of a little molecule found in every cell in your body that has a huge impact on aging. She specializes in the study of aging as a biologically complex disorder, specifically the role of NAD+ (Nicotinamide Adenine Dinucleotide).&nbsp;</p><p>You’re going to learn about how NAD+ works in the body from this scientist who was named one of 2021’s <a href="https://www.uktech.news/news/2021s-coolest-uk-female-founders-20210305" rel="noopener noreferrer" target="_blank">Coolest Female Founders of UK Tech Making Huge Impacts</a>.</p><p>Dr. Conlon says a key thing for people to understand is to go back to why NAD+ actually declines. “You really need to understand actually how NAD+ is produced by the cells when they're young.”</p><p>NAD+ is a natural molecule found in every cell in our bodies. It’s involved in energy production, helping convert the food you eat into the energy your cells need to stay alive. It is an activator of longevity proteins that are associated with cellular health and good aging, DNA repair and more. But as you get older, those NAD+ levels rapidly decline. Dr. Conlon explored why.</p><p>“It's become a lot more apparent recently that it's not just energy production that NAD+ is involved with,” Dr. Conlon says. “It's also involved in cellular maintenance and repair. It's almost like the fuel which switches on different enzymes and different processes. NAD+ is critical and actually driving DNA repair and making sure that DNA repair enzymes get to the damage site and do the job that is required.”</p><p>She says she got frustrated with the lag time between scientific discovery and actually getting new supplements and drugs to consumers—often a process of 10 to 15 years. “It's like all of science is encapsulated in this bubble, where it never actually gets out to real people in the outside world,” Dr. Conlon says.&nbsp;</p><p>So, she took her years of expertise focused on early stage drug